897 related articles for article (PubMed ID: 11008327)
1. Successful use of continuous intravenous prostacyclin in a patient with severe portopulmonary hypertension.
Kähler CM; Graziadei I; Wiedermann CJ; Kneussl MP; Vogel W
Wien Klin Wochenschr; 2000 Jul; 112(14):637-40. PubMed ID: 11008327
[TBL] [Abstract][Full Text] [Related]
2. Rapid normalization of portopulmonary hypertension after living donor liver transplantation.
Sugimachi K; Soejima Y; Morita K; Ueda S; Fukuhara T; Nagata S; Ikegami T; Taketomi A; Maehara Y
Transplant Proc; 2009 Jun; 41(5):1976-8. PubMed ID: 19545772
[TBL] [Abstract][Full Text] [Related]
3. Improvement in pulmonary hemodynamics during intravenous epoprostenol (prostacyclin): A study of 15 patients with moderate to severe portopulmonary hypertension.
Krowka MJ; Frantz RP; McGoon MD; Severson C; Plevak DJ; Wiesner RH
Hepatology; 1999 Sep; 30(3):641-8. PubMed ID: 10462369
[TBL] [Abstract][Full Text] [Related]
4. [Epoprostenol in the treatment of portopulmonary hypertension].
Culafić D; Culafić-Vojinović V; Jesić R
Srp Arh Celok Lek; 2003; 131(5-6):271-4. PubMed ID: 14692137
[TBL] [Abstract][Full Text] [Related]
5. Moderate-term effect of epoprostenol on severe portopulmonary hypertension.
Kato H; Katori T; Nakamura Y; Kawarasaki H
Pediatr Cardiol; 2003; 24(1):50-3. PubMed ID: 12574979
[TBL] [Abstract][Full Text] [Related]
6. Intraoperative epoprostenol and nitric oxide for severe pulmonary hypertension during orthotopic liver transplantation: a case report and review of the literature.
Vater Y; Martay K; Dembo G; Bowdle TA; Weinbroum AA
Med Sci Monit; 2006 Dec; 12(12):CS115-118. PubMed ID: 17136012
[TBL] [Abstract][Full Text] [Related]
7. Progressive splenomegaly after epoprostenol therapy in portopulmonary hypertension.
Findlay JY; Plevak DJ; Krowka MJ; Sack EM; Porayko MK
Liver Transpl Surg; 1999 Sep; 5(5):362-5. PubMed ID: 10477835
[TBL] [Abstract][Full Text] [Related]
8. Long-term follow-up of portopulmonary hypertension: effect of treatment with epoprostenol.
Fix OK; Bass NM; De Marco T; Merriman RB
Liver Transpl; 2007 Jun; 13(6):875-85. PubMed ID: 17539008
[TBL] [Abstract][Full Text] [Related]
9. Successful use of chronic epoprostenol as a bridge to liver transplantation in severe portopulmonary hypertension.
Plotkin JS; Kuo PC; Rubin LJ; Gaine S; Howell CD; Laurin J; Njoku MJ; Lim JW; Johnson LB
Transplantation; 1998 Feb; 65(4):457-9. PubMed ID: 9500616
[TBL] [Abstract][Full Text] [Related]
10. Extracorporeal membrane oxygenation rescue therapy in a case of portopulmonary hypertension during liver transplantation: a case report.
Stratta C; Lavezzo B; Ballaris MA; Panio A; Crucitti M; Andruetto P; Fanelli V; Grosso Marra W; Ranieri MV; Salizzoni M
Transplant Proc; 2013 Sep; 45(7):2774-5. PubMed ID: 24034045
[TBL] [Abstract][Full Text] [Related]
11. Successful management of portopulmonary hypertension with beraprost.
Kim EJ; Shin MS; Oh KY; Kim MG; Shin KC; Park YM; Kim BR; Chung WJ; Ahn TH; Choi IS; Shin EK
Eur J Gastroenterol Hepatol; 2010 Dec; 22(12):1503-5. PubMed ID: 21389799
[TBL] [Abstract][Full Text] [Related]
12. Pulmonary hemodynamics and perioperative cardiopulmonary-related mortality in patients with portopulmonary hypertension undergoing liver transplantation.
Krowka MJ; Plevak DJ; Findlay JY; Rosen CB; Wiesner RH; Krom RA
Liver Transpl; 2000 Jul; 6(4):443-50. PubMed ID: 10915166
[TBL] [Abstract][Full Text] [Related]
13. Successful adult-to-adult living donor liver transplantation in a patient with moderate to severe portopulmonary hypertension.
Uchiyama H; Soejima Y; Taketomi A; Yoshizumi T; Harada N; Ijichi H; Yonemura Y; Maehara Y
Liver Transpl; 2006 Mar; 12(3):481-4. PubMed ID: 16498645
[TBL] [Abstract][Full Text] [Related]
14. [Severe refractory pulmonary hypertension after liver transplantation for hepatitis C liver cirrhosis].
Dietrich CG; Gartung C; Siewert E; Lammert F; Matern S; Geier A
Z Gastroenterol; 2006 Jan; 44(1):33-7. PubMed ID: 16397837
[TBL] [Abstract][Full Text] [Related]
15. Portopulmonary hypertension.
Mukhtar NA; Fix OK
J Clin Gastroenterol; 2011 Sep; 45(8):703-10. PubMed ID: 21325952
[TBL] [Abstract][Full Text] [Related]
16. Portopulmonary hypertension and right heart failure in patients with cirrhosis.
Ramsay M
Curr Opin Anaesthesiol; 2010 Apr; 23(2):145-50. PubMed ID: 20124995
[TBL] [Abstract][Full Text] [Related]
17. Initial experience using continuous intravenous treprostinil to manage pulmonary arterial hypertension in patients with end-stage liver disease.
Sakai T; Planinsic RM; Mathier MA; de Vera ME; Venkataramanan R
Transpl Int; 2009 May; 22(5):554-61. PubMed ID: 19175541
[TBL] [Abstract][Full Text] [Related]
18. Prostacyclin in the management of pulmonary hypertension after heart transplantation.
Pascual JM; Fiorelli AI; Bellotti GM; Stolf NA; Jatene AD
J Heart Transplant; 1990; 9(6):644-51. PubMed ID: 2277302
[TBL] [Abstract][Full Text] [Related]
19. Intravenous epoprostenol in inoperable chronic thromboembolic pulmonary hypertension.
Cabrol S; Souza R; Jais X; Fadel E; Ali RH; Humbert M; Dartevelle P; Simonneau G; Sitbon O
J Heart Lung Transplant; 2007 Apr; 26(4):357-62. PubMed ID: 17403477
[TBL] [Abstract][Full Text] [Related]
20. Sustained improvement of performance and haemodynamics with long-term aerosolised prostacyclin therapy in severe pulmonary hypertension.
Stricker H; Domenighetti G; Fiori G; Mombelli G
Schweiz Med Wochenschr; 1999 Jun; 129(24):923-7. PubMed ID: 10413827
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
